Vanguard Group
TELA icon

Vanguard Group’s TELA Bio TELA Stock Holding History

Vanguard Group’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.16M Buy
1,830,550
+30,666
+2% +$38.8K ﹤0.01% 3534
2025
Q3 		$2.68M Sell
1,799,884
-111,694
-6% -$197K ﹤0.01% 3485
2025
Q2 		$3.71M Sell
1,911,578
-16,595
-0.9% -$21.7K ﹤0.01% 3309
2025
Q1 		$2.35M Buy
1,928,173
+52,594
+3% +$129K ﹤0.01% 3445
2024
Q4 		$5.66M Buy
1,875,579
+972,076
+108% +$2.73M ﹤0.01% 3227
2024
Q3 		$2.29M Hold
903,503
– – ﹤0.01% 3516
2024
Q2 		$4.25M Sell
903,503
-102,549
-10% -$541K ﹤0.01% 3323
2024
Q1 		$5.7M Buy
1,006,052
+7,199
+0.7% +$47.5K ﹤0.01% 3252
2023
Q4 		$6.61M Buy
998,853
+22,850
+2% +$132K ﹤0.01% 3174
2023
Q3 		$7.81M Buy
976,003
+107,484
+12% +$999K ﹤0.01% 3030
2023
Q2 		$8.8M Buy
868,519
+158,152
+22% +$1.62M ﹤0.01% 3021
2023
Q1 		$7.56M Buy
710,367
+35,132
+5% +$388K ﹤0.01% 3097
2022
Q4 		$7.77M Buy
675,235
+283,667
+72% +$2.54M ﹤0.01% 3070
2022
Q3 		$3.34M Hold
391,568
– – ﹤0.01% 3525
2022
Q2 		$2.75M Hold
391,568
– – ﹤0.01% 3673
2022
Q1 		$4.55M Buy
391,568
+43,633
+13% +$528K ﹤0.01% 3580
2021
Q4 		$4.45M Sell
347,935
-6,034
-2% -$76.4K ﹤0.01% 3673
2021
Q3 		$4.84M Buy
353,969
+11,689
+3% +$163K ﹤0.01% 3686
2021
Q2 		$5.51M Sell
342,280
-77,240
-18% -$1.06M ﹤0.01% 3543
2021
Q1 		$6.25M Buy
419,520
+20,721
+5% +$312K ﹤0.01% 3409
2020
Q4 		$6M Sell
398,799
-10,249
-3% -$166K ﹤0.01% 3277
2020
Q3 		$6.77M Buy
409,048
+166,356
+69% +$2.34M ﹤0.01% 2998
2020
Q2 		$3.15M Buy
242,692
+192,692
+385% +$2.53M ﹤0.01% 3294
2020
Q1 		$391K Hold
50,000
– – ﹤0.01% 3726
2019
Q4 		$647K Buy
+50,000
New +$611K ﹤0.01% 3745

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group's TELA Position: Q4 2025 in Review

Vanguard Group increased its TELA Bio (TELA) stake by 1.7% in Q4 2025, buying an estimated $38.8K and bringing the position to 1,830,550 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Vanguard Group first reported a position in TELA in Q4 2019 and has held it in 25 quarters since. The position peaked at $8.8M in Q2 2023. 42 funds tracked by Wall St. Rank hold TELA as of Q4 2025.

  • Vanguard Group held 1,830,550 shares of TELA Bio worth $2.16M as of Q4 2025.
  • Vanguard Group bought 30,666 TELA Bio shares in Q4 2025, an estimated $38.8K.
  • TELA Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3534 holding.
  • Vanguard Group first reported a position in TELA Bio in Q4 2019 and has held it in 25 quarters since.
  • Vanguard Group's TELA Bio position peaked at $8.8M in Q2 2023.
  • 42 funds tracked by Wall St. Rank held TELA Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.